new_0222_0465|PRAX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0465|PRAX|1|Praxis Precision Medicines Inc Total Current Assets (Quarterly) (USD)|Praxis Precision Medicines Inc Cash and Short Term Investments (Quarterly) (USD)|Praxis Precision Medicines Inc Inventories (Quarterly) (USD)|Praxis Precision Medicines Inc Net PP&E (Quarterly) (USD)|Praxis Precision Medicines Inc Goodwill and Intangibles (Quarterly) (USD)|Praxis Precision Medicines Inc Total Liabilities (Quarterly) (USD)|Praxis Precision Medicines Inc Total Current Liabilities (Quarterly) (USD)|Praxis Precision Medicines Inc Total Long Term Liabilities (Quarterly) (USD)|Praxis Precision Medicines Inc Total Deposits (Quarterly) (USD)|Praxis Precision Medicines Inc Book Value (Quarterly) (USD)|Praxis Precision Medicines Inc Retained Earnings (Quarterly) (USD)|Praxis Precision Medicines Inc Treasury Stock (Quarterly) (USD)|Praxis Precision Medicines Inc EV to Revenues|Praxis Precision Medicines Inc EV to Earnings|Praxis Precision Medicines Inc EV to Free Cash Flow|Praxis Precision Medicines Inc EV to Assets (Quarterly)|Praxis Precision Medicines Inc PS Ratio|Praxis Precision Medicines Inc PE Ratio|Praxis Precision Medicines Inc Price to Book Value|Praxis Precision Medicines Inc PEG Ratio|Praxis Precision Medicines Inc Debt to Equity Ratio|Praxis Precision Medicines Inc Dividend Yield|Praxis Precision Medicines Inc Shareholder Yield (TTM)|Praxis Precision Medicines Inc Percent of Shares Outstanding Short|Praxis Precision Medicines Inc Total Receivables (Quarterly) (USD)|Praxis Precision Medicines Inc Total Payables (Quarterly) (USD)|Praxis Precision Medicines Inc Total Capital Stock (Quarterly) (USD)|Praxis Precision Medicines Inc Return on Invested Capital|Praxis Precision Medicines Inc Quality Ratio Score|Praxis Precision Medicines Inc Momentum Score|Praxis Precision Medicines Inc Beta (1Y)|Praxis Precision Medicines Inc Sustainable Growth Rate (TTM)|Praxis Precision Medicines Inc Institutional Investor Ownership Percentage|Praxis Precision Medicines Inc Average Diluted Shares Outstanding (Quarterly)|Praxis Precision Medicines Inc Total Employees (Annual)|Praxis Precision Medicines Inc EPS Diluted (Quarterly) (USD)|Praxis Precision Medicines Inc Shares Outstanding|Praxis Precision Medicines Inc Repurchase of Capital Stock (Quarterly) (USD)|Praxis Precision Medicines Inc Ordinary Shares Number (Quarterly)|Praxis Precision Medicines Inc Payout Ratio|Praxis Precision Medicines Inc Quick Ratio (Quarterly)|Praxis Precision Medicines Inc Normalized Diluted EPS (Quarterly) (USD)|Praxis Precision Medicines Inc Stock Buybacks (Quarterly) (USD)|Praxis Precision Medicines Inc Effective Tax Rate (TTM)|Praxis Precision Medicines Inc Return on Equity|Praxis Precision Medicines Inc Net Income (TTM) (USD)|Praxis Precision Medicines Inc Revenue (TTM) (USD)|Praxis Precision Medicines Inc Dividend Per Share (Quarterly) (USD)|Praxis Precision Medicines Inc Revenue (Quarterly) (USD)|Praxis Precision Medicines Inc Gross Profit (Quarterly) (USD)|Praxis Precision Medicines Inc SG&A Expense (Quarterly) (USD)|Praxis Precision Medicines Inc Pre-Tax Income (Quarterly) (USD)|Praxis Precision Medicines Inc Net Income (Quarterly) (USD)|Praxis Precision Medicines Inc Net Interest Income (Quarterly) (USD)|Praxis Precision Medicines Inc Price (USD)|Praxis Precision Medicines Inc Total Return Price (USD)|Praxis Precision Medicines Inc Enterprise Value (USD)|Praxis Precision Medicines Inc 30-Day Average Daily Volume|Praxis Precision Medicines Inc 1 Year Price Returns (Daily)||
new_0222_0465|PRAX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0465|PRAX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0465|PRAX|5|106.5|106.5|0|106.5|0|106.5|106.5|106.5|0|106.5|106.5|0|0|0|1.44839857651|0|0|0|1.44839857651|0|0|1.45045045045|0|15.2666666667|0|106.5|106.5|0|0|31|30.6666666667|0|0|91.375|92|91.375|32.0833333333|91.3333333333|106.5|0|0|91.375|91.4|91.4|0|91.4|0|0|0|0|91.375|91.375|91.375|91.3333333333|1.45045045045|1.45045045045|1.45045045045|1.45065789474|1.43209876543||
new_0222_0465|PRAX|6|6|6|0|6|0|6|6|6|0|6|6|0|0|0|281|0|0|0|281|0|0|333|0|30|0|6|6|0|0|2|3|0|0|8|1|8|12|6|6|0|0|8|5|5|0|5|0|0|0|0|8|8|8|6|333|333|333|304|81||
new_0222_0465|PRAX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0465|PRAX|201909||||||||||||||||||||||||||||||||||17.1773||-0.6912||||||-0.6174|||||||||1.308|-10.606|-10.606|0.048|||||||
new_0222_0465|PRAX|201912|45.496|44.815||1.578||128.702|6.818|121.884||-81.008|-81.009|||||||||||||||2.667|0.001|||||||17.1773||-0.5302|||36.7497|||-0.4301|||||||||1.795|-7.472|-7.388|0.022|||||||
new_0222_0465|PRAX|202003||||||||||||||||||||||||||||||||||17.1773||-0.5764||-30||||-0.4849|||||||||1.601|-8.341|-8.33|0.128|||||||
new_0222_0465|PRAX|202006|20.44|19.748||1.217||8.547|8.157|0.39||14.106|-104.085|||||||||||||||3.688|0.002|||||||17.1773||-0.7922||0|36.7497|||-0.6734|0|0.2422||-37.892|||||2.52|-11.565|-11.568||||||||
new_0222_0465|PRAX|202009|115.851|114.772||1.031||242.811|10.384|232.427||-123.263|-123.264|||||||||||0||1.4783||3.452|0.001||||||11.0074|36.7497|51|-0.5485|36.7497|0|36.7497|||-0.4413|0|0.211||-43.502|||||3.431|-16.216|-16.216||35|35|1171.4675|252141.2||41.46|
new_0222_0465|PRAX|202012|302.326|296.608||0.836||15.72|15.72|0||287.457|-149.554||||-34.3752||||7.3247|||0||5.4009||4.088|0.004|||||||38.2685|67|-0.6966|38.2685|0|38.2685|||-0.6966|-200.886|0.0129||-61.82|||||9.44|-25.706|-25.706||55.02|55.02|1808.9249|339198.4||50.89|43.5
new_0222_0465|PRAX|202103|278.564|270.811||0.68||13.738|13.738|0||265.515|-176.927||||-14.2515||||4.7652|||0||5.2409||5.774|0.004|||||||38.4707||-0.71|38.621|0|38.621|||-0.71||-0.0037||-80.863|||||9.49|-27.373|-27.373|0.046|32.76|32.76|994.413|173084.6||30.66|19.59
new_0222_0465|PRAX|202106|348.433|339.184||4.582||19.739|15.78|3.959||333.772|-213.328||||-5.3181||||2.4478|||0||2.8184||7.401|0.005|||||||41.5698||-0.88|44.6932|0|44.6932|||-0.88|-98.576|0||-105.696|||||10.805|-36.401|-36.401||18.28|18.28|477.8077|496670.2||15.6|19.87
new_0222_0465|PRAX|202109|319.339|314.37||4.653||28.486|24.754|3.732||295.922|-258.033||||-5.1407||||2.7982|||0||3.6249||7.544|0.005|||2|2.1563|||44.7149||-1|44.7841|0|44.7841|||-1|0.096|-0.0037||-134.185|||||11.634|-44.7|-44.705||18.49|18.49|513.688|313788.9667|-39.1457|20.8|17.11
new_0222_0465|PRAX|202112|||||||||||||||-5.6972||||2.9861|||0||4.0566||||||2|1.8515||||||||||||||||||||||||19.7|19.7|569.2893|354054.5333|-64.1948|14.86|12.85